Lifevantage (LFVN) Projected to Post Earnings on Wednesday

Lifevantage (NASDAQ:LFVN) will likely be issuing its Q2 2026 results after the market closes on Wednesday, February 4th. Analysts expect Lifevantage to post earnings of $0.22 per share and revenue of $54.4020 million for the quarter. Lifevantage has set its FY 2026 guidance at 1.000-1.150 EPS. Interested persons can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 4:30 PM ET.

Lifevantage (NASDAQ:LFVN) last issued its earnings results on Tuesday, November 4th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. Lifevantage had a return on equity of 33.52% and a net margin of 4.43%.The business had revenue of $47.56 million for the quarter, compared to analysts’ expectations of $54.74 million.

Lifevantage Trading Up 1.5%

Shares of NASDAQ:LFVN opened at $5.95 on Wednesday. Lifevantage has a 1 year low of $5.47 and a 1 year high of $24.06. The business has a fifty day simple moving average of $6.35 and a 200 day simple moving average of $9.25. The firm has a market cap of $75.57 million, a price-to-earnings ratio of 7.73 and a beta of 0.34.

Lifevantage Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Monday, December 1st were paid a dividend of $0.045 per share. The ex-dividend date was Monday, December 1st. This represents a $0.18 dividend on an annualized basis and a yield of 3.0%. Lifevantage’s dividend payout ratio (DPR) is currently 23.38%.

Analyst Ratings Changes

LFVN has been the subject of several research reports. Wall Street Zen cut shares of Lifevantage from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Lake Street Capital reaffirmed a “buy” rating and set a $12.00 price objective on shares of Lifevantage in a research note on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Lifevantage in a research note on Monday, December 29th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.00.

Insider Activity

In related news, Director Michael A. Beindorff sold 35,000 shares of the stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $6.92, for a total transaction of $242,200.00. Following the completion of the sale, the director directly owned 56,413 shares of the company’s stock, valued at approximately $390,377.96. This trade represents a 38.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders sold 48,607 shares of company stock valued at $330,467 over the last three months. Corporate insiders own 21.95% of the company’s stock.

Hedge Funds Weigh In On Lifevantage

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LFVN. Wasatch Advisors LP grew its holdings in Lifevantage by 6.6% during the 2nd quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock valued at $5,838,000 after buying an additional 27,765 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Lifevantage by 106.1% in the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock valued at $3,210,000 after acquiring an additional 126,274 shares during the period. Two Sigma Investments LP grew its stake in Lifevantage by 60.6% during the third quarter. Two Sigma Investments LP now owns 88,071 shares of the company’s stock valued at $857,000 after acquiring an additional 33,242 shares in the last quarter. Squarepoint Ops LLC increased its holdings in Lifevantage by 68.1% during the 2nd quarter. Squarepoint Ops LLC now owns 70,507 shares of the company’s stock worth $922,000 after acquiring an additional 28,574 shares during the period. Finally, Man Group plc lifted its stake in Lifevantage by 72.5% in the 2nd quarter. Man Group plc now owns 53,098 shares of the company’s stock worth $695,000 after purchasing an additional 22,319 shares in the last quarter. Institutional investors own 35.32% of the company’s stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.